• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sagimet Biosciences Inc. - Series A Common Stock (NQ:SGMT)

    7.745 +0.595 (+8.32%)
    Streaming Delayed Price Updated: 12:31 PM EDT, Aug 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Sagimet Biosciences Inc. - Series A Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    US Stocks Higher; Nasdaq Jumps 100 Points ↗
    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Monday. Following the market opening Monday, the Dow traded up 0.55% to 38,073.10 while the NASDAQ rose... 
    Via Benzinga
    Topics Stocks
    News headline image
    Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
    Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged... 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences Announces Oral Presentation of Preclinical Results of FASN Inhibitor in Combination with Semaglutide at the 7th Obesity and NASH Drug Development Summit
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD - The Liver Meeting® 2023
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Sagimet Biosciences To Present at the H.C. Wainwright 7th Annual NASH Investor Conference
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
      On Thursday, 369 companies hit new 52-week lows. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Monday ↗
      On Monday, 369 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Wednesday ↗
      Wednesday's session saw 150 companies set new 52-week lows. 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
      On Tuesday, 386 stocks made new 52-week lows. 
    Via Benzinga
    News headline image
    Sagimet Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Sagimet Biosciences Announces Closing of Underwriters’ Option to Purchase Additional Shares of Series A Common Stock in Connection with its Upsized Initial Public Offering
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗
     
    Via Benzinga
    News headline image
    Sagimet Biosciences Announces Leadership Changes
    From Sagimet Biosciences Inc.
    Via GlobeNewswire
    News headline image
    Apogee, Sagimet Debut This Week In First Big IPOs Of Summer ↗
    Sagimet and Apogee both made their trading debuts this week, raising cash for their clinical trials after upsizing their respective IPOs. Inflammation and immunology biotech Apogee had the larger of... 
    Via Talk Markets
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.